Publications by authors named "Abin P Puravath"
Ixekizumab for Psoriatic Arthritis: Safety, Efficacy, and Patient Selection.
J Inflamm Res
December 2021
Article Synopsis
- Ixekizumab is a monoclonal antibody used for treating psoriasis and psoriatic arthritis (PsA), with the review focusing on its safety, efficacy from clinical trials, and the characteristics of study participants.
- The analysis covered 13 studies, showing that injection site reactions (ISR) occurred more frequently with ixekizumab than placebo or adalimumab, but it had fewer serious adverse events compared to adalimumab.
- Ixekizumab was found to be equally effective as adalimumab for PsA symptoms and even better for psoriasis outcomes, but the participant population was predominantly white and had high disease activity levels.